10x Genomics (TXG) Capital Expenditures Growth (1y) (2019 - 2026)

10x Genomics (TXG) Capital Expenditures Growth (1y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (1y) (Qtr)
1 Veeva Systems 26.11 Bn 18.79 Bn 662.02 Mn -70.37%
2 BrightSpring Health Services 12.95 Bn 12.07 Bn 482.22 Mn -64.78%
3 Healthequity 7.46 Bn 7.19 Bn 256.31 Mn 18,423.26%
4 Hinge Health 5.15 Bn 4.83 Bn 154.23 Mn -
5 Doximity 3.75 Bn 3.00 Bn 125.97 Mn 49.50%
6 10x Genomics 3.69 Bn 3.15 Bn 106.18 Mn -93.77%
7 Waystar Holding 3.61 Bn 3.45 Bn 268.04 Mn 182.47%
8 Privia Health 2.90 Bn 2.54 Bn 595.71 Mn -
9 Omnicell 1.72 Bn 1.54 Bn 140.36 Mn 1,174.08%
10 Teladoc Health 1.31 Bn 562.23 Mn 562.57 Mn 1,153.19%

Historic Data

Download Data
DateValue
Mar 31, 2026 -93.77%
Dec 31, 2025 -84.47%
Sep 30, 2025 114.21%
Jun 30, 2025 -59.42%
Mar 31, 2025 -0.32%
Dec 31, 2024 2,597.88%
Sep 30, 2024 82.11%
Jun 30, 2024 616.47%
Mar 31, 2024 -93.81%
Dec 31, 2023 -99.59%
Sep 30, 2023 -3.64%
Jun 30, 2023 -101.87%
Mar 31, 2023 104.14%
Dec 31, 2022 280.59%
Sep 30, 2022 -139.41%
Jun 30, 2022 758.13%
Mar 31, 2022 433.49%
Dec 31, 2021 -359.24%
Sep 30, 2021 12,894.89%
Jun 30, 2021 -60.86%